61 related articles for article (PubMed ID: 14684844)
1. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells.
Wu L; Iwai M; Li Z; Shiuchi T; Min LJ; Cui TX; Li JM; Okumura M; Nahmias C; Horiuchi M
Mol Endocrinol; 2004 Mar; 18(3):666-78. PubMed ID: 14684844
[TBL] [Abstract][Full Text] [Related]
2. NF-κB and CREB are required for angiotensin II type 1 receptor upregulation in neurons.
Haack KK; Mitra AK; Zucker IH
PLoS One; 2013; 8(11):e78695. PubMed ID: 24244341
[TBL] [Abstract][Full Text] [Related]
3. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.
Purcell NH; Tang G; Yu C; Mercurio F; DiDonato JA; Lin A
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6668-73. PubMed ID: 11381115
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of Phosphorylated Tyrosine into Proteins: In Vitro Translation and Study of Phosphorylated IκB-α and Its Interaction with NF-κB.
Chen S; Maini R; Bai X; Nangreave RC; Dedkova LM; Hecht SM
J Am Chem Soc; 2017 Oct; 139(40):14098-14108. PubMed ID: 28898075
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling.
Zhou Y; Little PJ; Xu S; Kamato D
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923651
[TBL] [Abstract][Full Text] [Related]
6. Expression of Concern: NF-κB and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons.
PLOS ONE Editors
PLoS One; 2023; 18(11):e0294092. PubMed ID: 37917764
[No Abstract] [Full Text] [Related]
7. Statement of Retraction: Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line.
J Chemother; 2024 Jan; ():1. PubMed ID: 38166589
[No Abstract] [Full Text] [Related]
8. Renin-Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19.
Ghimire B; Pour SK; Middleton E; Campbell RA; Nies MA; Aghazadeh-Habashi A
Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626615
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors.
Méndez-Valdés G; Pérez-Carreño V; Bragato MC; Hundahl M; Chichiarelli S; Saso L; Rodrigo R
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672525
[TBL] [Abstract][Full Text] [Related]
10. CGP42112: the full AT2 receptor agonist and its role in the renin-angiotensin-aldosterone system: no longer misunderstood.
Restrepo YM; Noto NM; Speth RC
Clin Sci (Lond); 2022 Nov; 136(21):1513-1533. PubMed ID: 36326719
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury.
Menk M; Graw JA; von Haefen C; Steinkraus H; Lachmann B; Spies CD; Schwaiberger D
J Inflamm Res; 2018; 11():169-178. PubMed ID: 29750051
[TBL] [Abstract][Full Text] [Related]
12. Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.
Labandeira-Garcia JL; Rodríguez-Perez AI; Garrido-Gil P; Rodriguez-Pallares J; Lanciego JL; Guerra MJ
Front Aging Neurosci; 2017; 9():129. PubMed ID: 28515690
[TBL] [Abstract][Full Text] [Related]
13. c-kit(+)AT2R(+) Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction.
Du M; Schmull S; Zhang W; Wang C; Lian F; Chen Y; Xue S
Stem Cells Int; 2016; 2016():4913515. PubMed ID: 27429622
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II Type 2-Receptor Agonist C21 Reduces Proteinuria and Oxidative Stress in Kidney of High-Salt-Fed Obese Zucker Rats.
Patel SN; Ali Q; Hussain T
Hypertension; 2016 May; 67(5):906-15. PubMed ID: 27021008
[TBL] [Abstract][Full Text] [Related]
15. Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-кB: possible role of ACE2.
Zhu L; Carretero OA; Xu J; Harding P; Ramadurai N; Gu X; Peterson E; Yang XP
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H827-34. PubMed ID: 26163449
[TBL] [Abstract][Full Text] [Related]
16. The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.
Skorska A; von Haehling S; Ludwig M; Lux CA; Gaebel R; Kleiner G; Klopsch C; Dong J; Curato C; Altarche-Xifró W; Slavic S; Unger T; Steinhoff G; Li J; David R
J Cell Mol Med; 2015 Aug; 19(8):1975-85. PubMed ID: 25991381
[TBL] [Abstract][Full Text] [Related]
17. Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo.
Sampson AK; Irvine JC; Shihata WA; Dragoljevic D; Lumsden N; Huet O; Barnes T; Unger T; Steckelings UM; Jennings GL; Widdop RE; Chin-Dusting JP
Br J Pharmacol; 2016 Feb; 173(4):729-40. PubMed ID: 25560767
[TBL] [Abstract][Full Text] [Related]
18. AT2 receptors targeting cardiac protection post-myocardial infarction.
Kaschina E; Lauer D; Schmerler P; Unger T; Steckelings UM
Curr Hypertens Rep; 2014 Jul; 16(7):441. PubMed ID: 24792092
[TBL] [Abstract][Full Text] [Related]
19. AT(2) receptor and tissue injury: therapeutic implications.
Namsolleck P; Recarti C; Foulquier S; Steckelings UM; Unger T
Curr Hypertens Rep; 2014 Feb; 16(2):416. PubMed ID: 24414230
[TBL] [Abstract][Full Text] [Related]
20. Impact of the AT(2) receptor agonist C21 on blood pressure and beyond.
Foulquier S; Steckelings UM; Unger T
Curr Hypertens Rep; 2012 Oct; 14(5):403-9. PubMed ID: 22836386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
